Newsroom | 66691 results

DARMSTADT, Germany--(BUSINESS WIRE)--Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer...

WASHINGTON--(BUSINESS WIRE)--CMMI has disrupted patient access, undermined providers, operated with little accountability, and wasted billions of taxpayer dollars....

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market (“Nasdaq”) from the NYSE American LLC (“NYSE American”). The Company expects that its common shares will cease trading on the NYSE American at market close...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--Podcast and YouTube participation rises dramatically at the Global Healthy Living Foundation...

DUBLIN--(BUSINESS WIRE)--The "ENT Disorder Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The ENT disorder treatment market is experiencing rapid transformation as organizations adopt new medical technologies and evolving care models to address complex clinical and operational challenges. Senior decision-makers are seeking strategies that enable both enhanced patient outcomes and sustainable organizational performance in this dynamic he...

DUBLIN--(BUSINESS WIRE)--The "Narcolepsy Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior leaders in the narcolepsy treatment market face an industry defined by technological advancement, shifting care expectations, and complex policy demands. Navigating this environment requires informed decision-making and operational agility to respond to rapid sector evolution. Narcolepsy Treatment Market Snapshot The global narcolepsy treatmen...

DUBLIN--(BUSINESS WIRE)--The "Central Nervous System Therapeutics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Central Nervous System Therapeutics was valued at US$107 Billion in 2024 and is projected to reach US$156.5 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. T...

DUBLIN--(BUSINESS WIRE)--The "Von Willebrand Disease Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior executives navigating the rare disease pharmaceutical sector require robust, reliable insights to address shifting patient demands, operational pressures, and evolving compliance frameworks. The Von Willebrand Disease Treatment Market presents both opportunities and challenges, making accurate market intelligence essential to infor...

LOS ANGELES--(BUSINESS WIRE)--Luskin Orthopaedic Institute for Children (LuskinOIC) Brings Holiday Cheer to 1,000 Children at 36th Annual Toys & Joy Celebration...